Global Osteoarthritis Gene Therapy Market Size study, by Site of Injection (Synovium, Cartilage) by Vectors (Non-viral, Retrovirus, Lentivirus, Adenovirus, Adeno-associated virus (AAV), HSV) by end use industries (Hospitals and clinics, Orthopedic Centers, Assisted living Facilities, Nursing, Homes, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027

BIZ4899460
200 Pages
January 2022
Pharmaceuticals

Download Sample Get Discount

Global Osteoarthritis Gene Therapy Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Osteoarthritis is a type of arthritis. arthritis affects millions of people worldwide. It occurs due to wear down of the protective cartilage that cushions the ends of the bones. The disorders most commonly affects joints in your hands, knees, hips, and spine. Rising prevalence of Osteoarthritis and increasing geriatric population are key driver for the growth of Osteoarthritis Gene Therapy. According to The Centers for Disease Control and Prevention’s estimates 1 in 4 (or 54.4 million) US adults have some form of arthritis, this figure is projected to reach 78 million by the year 2040 from 63 million in year 2020. As per Database company Statista’s estimates in 2019, the incidence of osteoarthritis of the knee in Europe was approximately 576 per 100,000 females and 419 per 100,000 males, making it the most common location of osteoarthritis. Furthermore, osteoarthritis of the hand occurred in 226 women per 100,000 and 134 men per 100,000. Also, with the surging healthcare infrastructure in emerging economies and rising technological advancements in field of Osteoarthritis Gene Therapy, the adoption & demand for Osteoarthritis Gene Therapy is likely to increase the market growth during the forecast period. However, high treatment cost of Osteoarthritis Gene Therapy impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Osteoarthritis Gene Therapy market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading/significant region across the world in terms of market share owing to rising prevalence of osteoarthritis cases in the region. Whereas North America is anticipated to exhibit highest growth rate / CAGR over the forecast period 2021-2027. Factors such as increasing government investments in various R&D activities in cell-based research would create lucrative growth prospects for the Osteoarthritis Gene Therapy market across Asia-Pacific region.

Major market player included in this report are:

Flexion

GeneQuine

Novartis

Smith & Nephew

Genascence

Kolon TissueGene

Sanofi

Paraxel

Medipost co ltd

Mundipharma.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Site of Injection:

Synovium

Cartilage

By Vectors:

Non-viral

Retrovirus

Lentivirus

Adenovirus

Adeno-associated virus (AAV)

HSV

By End Use Industries:

Hospitals and clinics

Orthopedic Centers

Assisted living Facilities

Nursing Homes

Ambulatory Surgical Centers

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Osteoarthritis Gene Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Osteoarthritis Gene Therapy Market, by Region, 2019-2027 (USD Billion)

1.2.2. Osteoarthritis Gene Therapy Market, by Site of Injection, 2019-2027 (USD Billion)

1.2.3. Osteoarthritis Gene Therapy Market, by Vectors, 2019-2027 (USD Billion)

1.2.4. Osteoarthritis Gene Therapy Market, by End Use Industries, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Osteoarthritis Gene Therapy Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Osteoarthritis Gene Therapy Market Dynamics

3.1. Osteoarthritis Gene Therapy Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Growing Prevalence of Osteoarthritis

3.1.1.2. increasing geriatric population

3.1.2. Market Challenges

3.1.2.1. High Treatment Cost.

3.1.3. Market Opportunities

3.1.3.1. Rising technological advancements in gene therapy

3.1.3.2. Surging Healthcare Infrastructure in emerging economies.

Chapter 4. Global Osteoarthritis Gene Therapy Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Osteoarthritis Gene Therapy Market, by Site of Injection

6.1. Market Snapshot

6.2. Global Osteoarthritis Gene Therapy Market by Site of Injection, Performance - Potential Analysis

6.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by Site of Injection 2018-2027 (USD Billion)

6.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis

6.4.1. Synovium

6.4.2. Cartilage

Chapter 7. Global Osteoarthritis Gene Therapy Market, by Vectors

7.1. Market Snapshot

7.2. Global Osteoarthritis Gene Therapy Market by Vectors, Performance - Potential Analysis

7.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by Vectors 2018-2027 (USD Billion)

7.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis

7.4.1. Non-viral

7.4.2. Retrovirus

7.4.3. Lentivirus

7.4.4. Adenovirus

7.4.5. Adeno-associated virus (AAV)

7.4.6. HSV

Chapter 8. Global Osteoarthritis Gene Therapy Market, by End Use Industries

8.1. Market Snapshot

8.2. Global Osteoarthritis Gene Therapy Market by End Use Industries, Performance - Potential Analysis

8.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by End Use Industries 2018-2027 (USD Billion)

8.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis

8.4.1. Hospitals and clinics

8.4.2. Orthopedic Centers

8.4.3. Assisted living Facilities

8.4.4. Nursing Homes

8.4.5. Ambulatory Surgical Centers

8.4.6. Others

Chapter 9. Global Osteoarthritis Gene Therapy Market, Regional Analysis

9.1. Osteoarthritis Gene Therapy Market, Regional Market Snapshot

9.2. North America Osteoarthritis Gene Therapy Market

9.2.1. U.S. Osteoarthritis Gene Therapy Market

9.2.1.1. Site of Injection breakdown estimates & forecasts, 2018-2027

9.2.1.2. Vectors breakdown estimates & forecasts, 2018-2027

9.2.1.3. End Use Industries breakdown estimates & forecasts, 2018-2027

9.2.2. Canada Osteoarthritis Gene Therapy Market

9.3. Europe Osteoarthritis Gene Therapy Market Snapshot

9.3.1. U.K. Osteoarthritis Gene Therapy Market

9.3.2. Germany Osteoarthritis Gene Therapy Market

9.3.3. France Osteoarthritis Gene Therapy Market

9.3.4. Spain Osteoarthritis Gene Therapy Market

9.3.5. Italy Osteoarthritis Gene Therapy Market

9.3.6. Rest of Europe Osteoarthritis Gene Therapy Market

9.4. Asia-Pacific Osteoarthritis Gene Therapy Market Snapshot

9.4.1. China Osteoarthritis Gene Therapy Market

9.4.2. India Osteoarthritis Gene Therapy Market

9.4.3. Japan Osteoarthritis Gene Therapy Market

9.4.4. Australia Osteoarthritis Gene Therapy Market

9.4.5. South Korea Osteoarthritis Gene Therapy Market

9.4.6. Rest of Asia Pacific Osteoarthritis Gene Therapy Market

9.5. Latin America Osteoarthritis Gene Therapy Market Snapshot

9.5.1. Brazil Osteoarthritis Gene Therapy Market

9.5.2. Mexico Osteoarthritis Gene Therapy Market

9.6. Rest of The World Osteoarthritis Gene Therapy Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Flexion

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. GeneQuine

10.2.3. Novartis

10.2.4. Smith & Nephew

10.2.5. Genascence

10.2.6. Kolon TissueGene

10.2.7. Sanofi

10.2.8. Paraxel

10.2.9. Medipost co ltd

10.2.10. Mundipharma

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Osteoarthritis Gene Therapy market, report scope

TABLE 2. Global Osteoarthritis Gene Therapy market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Osteoarthritis Gene Therapy market estimates & forecasts by Site of Injection 2018-2027 (USD Billion)

TABLE 4. Global Osteoarthritis Gene Therapy market estimates & forecasts by Vectors 2018-2027 (USD Billion)

TABLE 5. Global Osteoarthritis Gene Therapy market estimates & forecasts by End Use Industries 2018-2027 (USD Billion)

TABLE 6. Global Osteoarthritis Gene Therapy market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Osteoarthritis Gene Therapy market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Osteoarthritis Gene Therapy market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Osteoarthritis Gene Therapy market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Osteoarthritis Gene Therapy market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Osteoarthritis Gene Therapy market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Osteoarthritis Gene Therapy market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Osteoarthritis Gene Therapy market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Osteoarthritis Gene Therapy market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Osteoarthritis Gene Therapy market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. U.S. Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. U.S. Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 19. Canada Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Canada Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. Canada Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. UK Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. UK Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. UK Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. Germany Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 26. Germany Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Germany Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. RoE Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 29. RoE Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. RoE Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. China Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 32. China Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. China Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. India Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 35. India Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. India Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. Japan Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 38. Japan Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Japan Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. RoAPAC Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 41. RoAPAC Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. RoAPAC Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Brazil Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 44. Brazil Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Brazil Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Mexico Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 47. Mexico Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Mexico Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. RoLA Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 50. RoLA Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. RoLA Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. Row Osteoarthritis Gene Therapy market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 53. Row Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Row Osteoarthritis Gene Therapy market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global Osteoarthritis Gene Therapy market

TABLE 56. List of primary sources, used in the study of global Osteoarthritis Gene Therapy market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara